Aubagio
teriflunomide
- Strength
- 14 mg/1
- Form
- Tablet, Film Coated
- Class
- Pyrimidine Synthesis Inhibitor
Genzyme Corporation
Not stocked by us — reference only
Listed by Glenmark Pharmaceuticals Inc., USA
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Pyrimidine Synthesis Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 68462-423 |
| FDA application | ANDA209663 |
| RxNorm concept | 1310525 |
| Package sizes listed | 3 |
| Marketed since | January 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
teriflunomide
Genzyme Corporation
Not stocked by us — reference only
teriflunomide
Genzyme Corporation
Not stocked by us — reference only
Alembic Pharmaceuticals Limited
Not stocked by us — reference only
MSN LABORATORIES PRIVATE LIMITED
Not stocked by us — reference only
Zydus Lifesciences Limited
Not stocked by us — reference only
Accord Healthcare Inc.
Not stocked by us — reference only
Camber Pharmaceuticals, Inc.
Not stocked by us — reference only
Camber Pharmaceuticals, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.